TABLE 2.

Change in adherence to antihypertensive drugs between baseline (t0) and 12 months (t12) of follow-up

	Adherent (t0) – Adherent (t12)	Adherent (t0) – Nonadherenta (t12)	Nonadherent (t0) – Adherent (t12)	Nonadherent (t0) – Nonadherent (t12)	P [χ2 (3)]
SoC arm (n = 42) n (%)	23 (54.8)	7 (16.7)	7 (16.7)	5 (11.9)	0.086
Intervention+SoC arm (n = 40) n (%)	27 (67.5)	1 (2.5)	10 (25.0)	2 (5.0)

n, number of patients; SoC, standard of care; t0, baseline; t12, 12 months follow-up.

^aNonadherence is defined as the absence of one or more measured antihypertensive drug concentrations in blood used by the patient.